Literature DB >> 6218779

Determination of cefoperazone concentration in serum and muscle tissue with a versatile high-pressure liquid chromatographic method.

R R Muder, W F Diven, V L Yu, J Johnson.   

Abstract

A rapid, specific, and reproducible high-pressure liquid chromatographic method was developed for the determination of cefoperazone concentration in serum and tissue. The assay uses a simple methanol extraction, with cefoxitin as the internal standard. The limits of detection are 1 to 150 micrograms/ml; the maximum coefficient of variation is 7.4%. Using the same chromatography column, muBondapak phenyl, and mobile-phase 0.005 M tetrabutylammonium buffer-acetonitrile (80:20), the method can be easily adapted for the analysis of cefoxitin and moxalactam.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6218779      PMCID: PMC185726          DOI: 10.1128/AAC.22.6.1076

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  6 in total

1.  Comparative pharmacokinetics of cefoperazone and cefamandole.

Authors:  S Srinivasan; E L Francke; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1981-02       Impact factor: 5.191

2.  Measurement of serum and tissue concentration of moxalactam using high pressure liquid chromatography.

Authors:  W F Diven; B D Obermeyer; R L Wolen; V L Yu; J Lyon; J Zuravleff
Journal:  Ther Drug Monit       Date:  1981       Impact factor: 3.681

3.  Comparative activities of the oxa-beta-lactam LY127935, cefotaxime, cefoperazone, cefamandole, and ticarcillin against multiply resistant gram-negative bacilli.

Authors:  W H Hall; B J Opfer; D N Gerding
Journal:  Antimicrob Agents Chemother       Date:  1980-02       Impact factor: 5.191

4.  In vitro antibacterial activity of cefoperazone (T-1551), a new semisynthetic cephalosporin.

Authors:  N Matsubara; S Minami; T Muraoka; I Saikawa; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1979-12       Impact factor: 5.191

5.  Comparison of cefoperazone, cefotaxime, and moxalactam (LY127935) against aerobic gram-negative bacilli.

Authors:  S D Lang; D J Edwards; D T Durack
Journal:  Antimicrob Agents Chemother       Date:  1980-03       Impact factor: 5.191

6.  Pharmacokinetics of cefoperazone in patients with neoplastic disease.

Authors:  A W Maksymiuk; B M LeBlanc; N S Brown; D H Ho; G P Bodey
Journal:  Antimicrob Agents Chemother       Date:  1981-06       Impact factor: 5.191

  6 in total
  3 in total

1.  Recent analytical methods for cephalosporins in biological fluids.

Authors:  R D Toothaker; D S Wright; L A Pachla
Journal:  Antimicrob Agents Chemother       Date:  1987-08       Impact factor: 5.191

2.  Penetration of cefoperazone into surgical wound drainage in patients undergoing head and neck surgery.

Authors:  R R Muder; V L Yu; J Johnson; P Thearle; J Lyon; W Diven
Journal:  Antimicrob Agents Chemother       Date:  1984-04       Impact factor: 5.191

Review 3.  Clinical pharmacokinetics of the third generation cephalosporins.

Authors:  L Balant; P Dayer; R Auckenthaler
Journal:  Clin Pharmacokinet       Date:  1985 Mar-Apr       Impact factor: 6.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.